Arif Khan

19PUBLICATIONS
33CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 12, 2026
Liposomal Methylglyoxal Targets Virulence and Intracellular Persistence to Overcome Amphotericin B Resistance in Cryptococcus neoformans.

|Mar 28, 2026
Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances.

Abdulaziz A Aloliqi, Abdullah M Alnuqaydan, Mohammad Alshebremi

|Jun 27, 2025
Targeting Azole-Resistant Candida albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection.

Masood A Khan, Arif Khan, Abdullah M Alnuqaydan

|Apr 26, 2025
Lipid-Based Nanoformulations of [6]-Gingerol for the Chemoprevention of Benzo[a] Pyrene-Induced Lung Carcinogenesis: Preclinical Evidence.

Faris Alrumaihi, Ali Yousif Babiker, Arif Khan

|Apr 26, 2025
Preclinical and Molecular Docking Insights into the Chemopreventive Role of Fenugreek Seed Extract in a Murine Model of Colorectal Cancer.

Arif Khan, Khaled S Allemailem, Arwa Essa Alradhi

|Apr 15, 2022
Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice.

Arif Khan, Mohammed A Alsahli, Mohammad A Aljasir

Pageof 4

Frequent Collaborators

16 joint publications

Masood Alam Khan

12 joint publications

Faris Alrumaihi

12 joint publications

Khaled S Allemailem

11 joint publications

Ahmed A Almatroudi